Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · MICROVISION, INC. (MVIS)

MicroVision Q3 revenue rises to $2.4 million; net loss narrows to $12.2 million

Positive Impact 3 of 5 earnings Written later

MicroVision reported third quarter 2026 revenue of $2.4 million, up from $0.2 million a year earlier, and a net loss of $12.2 million, or $0.45 per share, versus $14.2 million, or $0.72 per share, in the prior-year quarter. The company reiterated its full year 2026 revenue outlook of $10 million to $15 million and said it expects operating cash burn to fall to about $40 million in 2027, with cost reductions planned for the fourth quarter.

Key points

  • Q3 2026 revenue was $2.4 million versus $241 thousand in Q3 2025; gross margin was 50%.
  • Net loss was $12.2 million ($0.45 per share), including a $6.3 million German government R&D grant in the quarter.
  • Full year 2026 revenue outlook of $10 million to $15 million was reiterated; 2027 revenue is expected to at least double the expected 2026 level.
  • Cash and cash equivalents were $28.9 million as of September 30, 2026; cash used in operations was $13.6 million in the quarter.

The filing

CompanyMICROVISION, INC. (MVIS)
Form8-K, current report
Filed with the SECOct 28, 2026, 4:11 PM ET
Accession number0001493152-26-048989

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:51 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 28, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.